Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (491-500 of 706) with videos related to

Pageof 71
Sort By:
JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.
American Heart Journal|December 18, 2007
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 studyC Michael Gibson, Sabina A Murphy, Yuri B Pride, et al.
Circulation. Cardiovascular Quality and Outcomes|February 27, 2014
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease ProgramKevin R Bainey, Paul W Armstrong, Gregg C Fonarow, et al.
JACC. Cardiooncology|August 16, 2021
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-ITRobert P Giugliano, Baris Gencer, Stephen D Wiviott, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Journal of the American Heart Association|October 26, 2017
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) TrialClaes Held, Harvey D White, Ralph A H Stewart, et al.
American Heart Journal|December 9, 2008
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromesChristopher P Cannon, Robert P Giugliano, Michael A Blazing, et al.
Journal of the American College of Cardiology|January 10, 2009
Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) RegistryDeborah B Diercks, Michael C Kontos, Anita Y Chen, et al.
Circulation. Cardiovascular Interventions|April 8, 2020
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI TrialNatalia C Berry, Laura Mauri, Philippe Gabriel Steg, et al.
The New England Journal of Medicine|March 11, 2005
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevationMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.
Pageof 71

Showing results (491-500 of 706) with videos related to

Sort By:
Pageof 71
JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.
American Heart Journal|December 18, 2007
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 studyC Michael Gibson, Sabina A Murphy, Yuri B Pride, et al.
Circulation. Cardiovascular Quality and Outcomes|February 27, 2014
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease ProgramKevin R Bainey, Paul W Armstrong, Gregg C Fonarow, et al.
JACC. Cardiooncology|August 16, 2021
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-ITRobert P Giugliano, Baris Gencer, Stephen D Wiviott, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Journal of the American Heart Association|October 26, 2017
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) TrialClaes Held, Harvey D White, Ralph A H Stewart, et al.
American Heart Journal|December 9, 2008
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromesChristopher P Cannon, Robert P Giugliano, Michael A Blazing, et al.
Journal of the American College of Cardiology|January 10, 2009
Utilization and impact of pre-hospital electrocardiograms for patients with acute ST-segment elevation myocardial infarction: data from the NCDR (National Cardiovascular Data Registry) ACTION (Acute Coronary Treatment and Intervention Outcomes Network) RegistryDeborah B Diercks, Michael C Kontos, Anita Y Chen, et al.
Circulation. Cardiovascular Interventions|April 8, 2020
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI TrialNatalia C Berry, Laura Mauri, Philippe Gabriel Steg, et al.
The New England Journal of Medicine|March 11, 2005
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevationMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.
Pageof 71